Cargando…
Limitations of the Barcelona clinic liver cancer staging treatment strategy in hepatocellular carcinoma patients with performance status 1
Autores principales: | Yu, Jung Hwan, Lee, Jin-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575991/ https://www.ncbi.nlm.nih.gov/pubmed/33145261 http://dx.doi.org/10.21037/atm-20-4316 |
Ejemplares similares
-
Treatment of Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma: liver resection versus TACE and beyond
por: Huo, Ya Ruth, et al.
Publicado: (2020) -
Is the Barcelona Clinic Liver Cancer guideline for treating intermediate to advanced staged hepatocellular carcinoma still appropriate?
por: Kang, Koo Jeong, et al.
Publicado: (2021) -
Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy
por: Guarino, Maria, et al.
Publicado: (2020) -
Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment
por: Jun, Chung Hwan, et al.
Publicado: (2017) -
Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B
por: Huang, Cheng, et al.
Publicado: (2017)